Biotech API Offers Growth Opportunities In The European API Market
10/23/2009

Bharatbook.com added a new report on "Europe Active Pharmaceuticals Ingredients Market Analysis and Forecasts to 2020" focus the Growth Of The Innovative Sector Of The Synthetic API Market In Europe.

Online PR News – 23-October-2009 – – ‘Europe Active Pharmaceuticals Ingredients Market Analysis and Forecasts to 2020’ provides in-depth analysis of the European Active Pharmaceutical Ingredients (API) market and presents revenue forecasts up to 2020 for the key countries – UK, Germany, France and Italy. The report is based around the two major product types, namely, synthetic API and biotech API. Revenue forecasts are provided for both the product types. The synthetic API market is further analyzed based on the customer base – generic and innovative sectors. This study also provides detailed insights into the factors affecting the dynamics of the market with strategic analysis of the major trends. Market share analysis of the major companies in the whole European market is also covered in the report. ( http://www.bharatbook.com/Market-Research-Reports/Europe-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts-to-2020.html )

France Set To Lead The Growth Of The European API Market

France is set to lead the overall growth of the European API market at a rate higher than other Western European countries. The growth in the French API market will be primarily driven by the increased demand for APIs in the generic sector and the faster growth of the biotech API market. Historically, the generic sector of the synthetic API market in France has been underdeveloped as higher focus was laid upon the innovative sector. However, in the wake of economic recession, the government’s cost-containment policies have given way for increased focus on the generic sector of the country. This is expected to drive the overall growth of the API market in the country. Additionally, the developing biotech API market will be growing at higher rates than other countries in the Western Europe such as the UK and Germany. The cumulative effect of these two factors will keep the API market in France growing at a rate higher than other Western European countries.
The French API market is expected to grow at a CAGR of 6.95% from 2008 to 2020.

Economic Recession Negatively Impacts The Growth Of The Innovative Sector Of The Synthetic API Market In Europe

The innovative sector of the synthetic API market is to be worse hit by the ongoing economic crisis in Europe. Western Europe has historically been dominated by the innovative sector in its API market. However, with the economic downturn, many of the countries are resorting to cost-containment measures in order to reduce the overall healthcare expenditure. This will be detrimental to the growth of the innovative sector as these policies will lay emphasis on improving the growth of the generic sector, which incurs lower cost. This increased focus on the generics sector in the European region will curb the growth of the innovative sector in the European synthetic API market. The total innovative synthetic API in the European region is expected to grow at a CAGR around 4% from 2008 to 2020 whereas the generic sector will be growing at a CAGR around 7% for the same period.

Biotech API Offers Growth Opportunities In The European API Market

The biotech API market in Europe is up for higher growth than the synthetic API market thereby offering good growth opportunities for the producers. The focus on biological drugs in Europe is increasing which is set to drive the growth of the biotech API market. The biosimilars market will also get a boost in the next few years as many of the biological drugs are expected to go off-patent. This will boost the overall growth of the biotech APIs in Europe enabling it to grow faster than the synthetic API market. The biotech API market is expected to grow at a CAGR of around 9% from 2008 to 2020.

Italian API Market Set To Grow Around 5%, Slowest In Europe

The Italian API market will be the slowest growing market in the European region due to the combined effect of market maturity and the impact of economic recession. It is expected to grow at a CAGR of 5% during the period 2008-2020. The Italian pharmaceutical industry has been posting very slow growth rate for the past two years which is likely to be further worsened by the ongoing financial crisis. This is set to restrict the growth of the API market in Italy making it the slowest growing country in the whole of European region.

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/Europe-Active-Pharmaceutical-Ingredients-Market-Analysis-and-Forecasts-to-2020.html

Or

Contact us at :
 
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: press@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook